Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.04 | 1.93 |
NAV | ₹19.02 | ₹37.55 |
Fund Started | 06 Oct 2020 | 25 Jun 2018 |
Fund Size | ₹156.68 Cr | ₹5024.00 Cr |
Exit Load | - | Exit load of 1% if redeemed within 15 days. |
Returns
1 Year | 33.82% | 50.65% |
3 Year | 14.99% | 22.29% |
5 Year | - | 30.36% |
Holding Analysis
Equity | 99.93% | 97.87% |
Cash | 0.01% | 2.13% |
Top Holdings
Top 10 Holdings |
|
|
Fund Manager
Name | Bhavesh Jain | Dharmesh Kakkad |
Start Date | 01 Oct 2021 | 23 Feb 2021 |
About Fund
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 06 Oct 2020 | 25 Jun 2018 |
